Developing Novel Therapies to Enable Life Unburdened by Alcohol & Drug Abuse

Alcohol Use Disorder Prevalence, Mortality, and Economic Impact

Adults with AUD in US
30M
>10% of US adults (12-month prevalence 2021)1
Increase of AUD in women
84%
35% increase among men during same 10 year period2
Increase in deaths from chronic health issues
32%
Over 117k deaths in 20213
Increase in acute death
24%
over 61k deaths in 20214
Annual economic cost
$249B
Loss of workplace productivity, healthcare costs, and criminal justice (est 2010)5
Annual healthcare costs
$104B
Attributed to alcohol-related health care in US6
WHY WE CREATED SOPHROSYNE

The Problem to Solve – AUD Causes Health, Economic, and Societal Havoc in the U.S. and Around the World

Very large addressable market

  • Approximately 30 million people in the U.S.
  • Approximately 400 million people globally7
  • Significant rise in AUD among women

Health impact on the individual and community

  • 3rd leading cause of preventable morbidity and mortality8
  • Estimated 200k alcohol related deaths per year in the U.S.9
  • Approximately 15k alcohol related traffic deaths per year in the U.S10
  • More than 100K alcohol related cancer deaths per year11
  • Leading cause of liver disease

Economic burden on society

  • Total cost-burden estimated to exceed $300 Billion per year in U.S.
  • 232 million missed work-days annualy in the U.S.12
  • Criminal justice alcohol related expenditure estimated to exceed $100 Billion per year - more than 1 million DUI arrests per year in U.S.13

Interested in more information on partnership or licensing opportunities?